Everything government, Parliament, the statistical agencies and the major policy institutes published — read, summarised and ranked so you can skim the day in a minute.
Sets out the MHRA’s regulatory position to encourage development and licensing of Microbiome‑Based Medicinal Products (MBMPs) in the UK, clarifying expectations for safety, quality and clinical evidence to support market authorisation.
Department of Health and Social Care sets out information on medical stockpiles it holds and related arrangements intended to ensure availability of supplies during public health emergencies, covering the department’s preparedness role.
The MHRA has published a 2026 consultation on statutory fees proposing adjustments to ongoing cost‑recovery arrangements and funding for higher‑value regulatory services.
Sets out the Department of Health and Social Care’s five‑year plan to expand British Sign Language use in its communications, aiming to improve accessibility of health guidance, patient information and engagement with BSL users across health services.